baber/WOPTO huggingface dataset:
Patent NZ-285412-A (NZ)
Title: Gas inflatable balloon, connetable via line to ground, with electrical illumination controllable by switch dependent upon balloon pressure or shape
Inventor: CHABERT PIERRE GABRIEL
IPC: F21S8/00
Filed: 1995-04-27
Abstract: The balloon (1) has a flexible outer surface (1) which is connected an electric cable with an outer sheath (27). A sealed connection through the balloon wall is made by an outer plate (4) with inner ring and sealed connections (13). Nut connections (28) on the outer wall allow connection to an inner section. The cable connects a power source on the ground to a light in the centre of the balloon. An actuation device inside the balloon consists of a spring (7) which is tensioned by a flexible connector and connected to the loop (17) of a two-sided pin (19). Switches (25) are positioned between the power source and the light. A wire (5) links part of the surface and the actuator which is positioned at another location at the surface periphery. The pin has a sliding holder (24) and an inner spring (15). The pin base (21) is clear of the switch (26) when the balloon is inflated, but pushes the switch closed when the balloon is deflated, switching off the electricity. <IMAGE>
Patent NZ-307053-A (NZ)
Title: Method for making quinolone carboxylic acids or naphthyridine carboxylic acids in free base form
Inventor: DOZEMAN GARY JAY
IPC: A61P31/04
Filed: 1996-04-26
Abstract: The present invention provides a method of making quinolone carboxylic acids or naphthyridine carboxylic acids in free base form, the method comprising dissolving a quinolone carboxylic acid salt or naphthyridine carboxylic acid salt in a solvent system to form a solution; combining the solution containing the quinolone carboxylic acid salt or naphthyridine carboxylic acid salt with a calcium salt in an amount in the range of about 0.01% to about 5.0% by weight of the quinolone carboxylic acid salt or naphthyridine carboxylic acid salt and a base, the combination resulting in the formation of a precipitate; and collecting the precipitate. Also provided is a solid bulk pharmaceutical chemical composition which is the product resulting from the precipitation.
Patent NZ-315634-A (NZ)
Title: Halobenzimidazoles and their use as microbicides
Inventor: ASSMANN LUTZ
IPC: C07D491/056
Filed: 1996-07-29
Abstract: PCT No. PCT/EP96/03334 Sec. 371 Date Jan. 28, 1998 Sec. 102(e) Date Jan. 28, 1998 PCT Filed Jul. 29, 1996 PCT Pub. No. WO97/06171 PCT Pub. Date Feb. 20, 1997New halogenobenzimidazoles of the formula in which A, R1, R2, R3, R4 and X have the meanings given in the description, and their acid addition salts and metal salt complexes, a process for their preparation and their use as microbicides in crop protection and in the protection of materials. New intermediates of the formula in which R12-R17 and X have the meanings given in the description, and processes for the preparation of these substances.
Patent NZ-329202-A (NZ)
Title: Treatments for ameliorating the effects of psoriasis using compounds that inhibit cell proliferative and/or inflammation
Inventor: WERTHER GEORGE ARTHUR
IPC: C12N15/11
Filed: 1995-07-06
Abstract: Provided is a method of ameliorating the effects of psoriasis using compounds, such as nucleic acids and in particular, with properties that inhibit IGF-I mediated cell proliferation and/or inflammation.  It is preferred to treat psoriasis with a polynucleotide capable of interacting with mRNA directed from an IGF-I gene, an IGF-I receptor gene or a gene encoding an IGFBP, particularly a polynuclotides of the following sequence: 5'-ATCTCTCCGCTTCCTTTC-3'
Patent NZ-336165-A (NZ)
Title: Water purification process, heat exchange surfaces on evaporation side of reboiler kept wetted to reduce fouling
Inventor: KRESNYAK STEVE
IPC: B01D1/00
Filed: 1998-01-14
Abstract: A contaminated feed stream is pretreated at 12 to remove volatiles 14 and insolubles 16, then preheated at exchanger 18. The fluid is then passed to a heated separator 20 to generate a vapour fraction 30 and a concentrate "blowdown" fraction 24 containing the contaminants.   The vapour fraction is compressed in compressor 32 to raise its temperature above the temperature of the concentrate.  The heated vapour fraction (mostly superheated steam) is then passed to a reboiler exchanger 34.  In the reboiler, the vapour fraction is cooled by a recirculating concentrate stream 38 from separator 20, to produce a clean distillate stream collected at 36 and from which the sensible heat is recovered in the preheater 18.   The flow rate of the recirculating concentrate stream 38, set by pump 42 and throttling valve 44, is adjusted so that the ratio of circulating mass to vapour mass is between 100:1 and 10:1.  Thus, the vapour generated in stream 38 is equivalent in mass to the amount passing through the compressor and recovered as distillate.  The vapour generated in the reboiler maintains a fully wetted heat transfer surface on the evaporating side of the reboiler, which reduces the risk of fouling or scaling.
Patent NZ-337943-A (NZ)
Title: A method of treating cement clinker to enhance the strength properties
Inventor: RONIN VLADIMIR
IPC: C04B28/02
Filed: 1998-03-23
Abstract: A method of treating cement clinker by grinding the clinker in a tubular mill while charging water, gypsum and possibly also a water-reduction agent to the mill at the same time, and is characterised by the water having a pH of 9-13 and is injected into the mill during grinding of the clinkers to form a slurry. The solid to slurry ratio is between 95 weight %:5 weight % to 85 weight %:15 weight %. The method is characterised by charging to the mill a microfill agent in the form of SiO2-containing substances in an amount corresponding to 80% of the combined weight of the microfill agent, water-reduction agent and water charged.
Patent NZ-502409-A (NZ)
Title: Hair conditioning compositions containing alpha or beta hydroxy acid esters
Inventor: DEEGAN CHARLENE PATRICIA
IPC: A61K8/89
Filed: 1998-07-20
Abstract: Described is a hair conditioner composition comprising, by weight of the total composition: 0.1-20% of a cationic conditioning agent, 0.1-20% of esters of alpha or beta hydroxy acids, 0.1-30% of a fatty alcohol, 0.001-10% of a nonionic surfactant, and 5-95% water.
Patent NZ-506257-A (NZ)
Title: Buoyancy material constructed of metallic spheres and syntactic foam
Inventor: HENKENER JERRY ALLEN
IPC: B63B3/13
Filed: 1999-03-05
Abstract: The formation of pressure resistant buoyancy structures (20) with a given buoyancy efficiency at smaller sizes comprising embedding into syntactic foam, metallic spheres (10) which are substantially hollow and comprise high strength, high performance, light weight metal alloys which can be precision forged.  The weight per unit space of the metallic spheres (10) is less than that of the syntactic foam.  As a result, the metallic spheres can decrease the size of the structure required to achieve desired buoyancy efficiency.
Patent NZ-508535-A (NZ)
Title: 17-Halogenated 19-nor steroid derivatives useful for treating or preventing osteoporosis, cardiovascular disorders, menopause or perimenopause
Inventor: VAN DE VELDE PATRICK
IPC: C07J41/00
Filed: 1999-06-22
Abstract: A 17-halogenated-19-nor-steroid derivative or a salt thereof has the formula (I) wherein: R1 is H, -(CH2)m-Ar, -(CO)-Ar, -(CH2)m-Alk, or -C(O)-Alk; R2 is a hydrocarbon of 1 to 6 carbons; X is halogen; Y is a bond, O, NH, S, SO or SO2; Z is H or halogen; n is 2 to 5; R3 and R4 independently are H, -(CH2)m'-Ar, -(CH2)m'-Het or -(CH2)m'-Alk or NR3R4 forms a optionally saturated, optionally substituted  3 to 15 membered heterocycle containing 1 to 3 additional heteroatoms of oxygen, sulphur, nitrogen; m' and m are independently 0 to 3 and the dotted lines represent an optional second bond. A pharmaceutical composition thereof is useful for treating or preventing osteoporosis, cardiovascular disorders, menopause or perimenopause.
Patent NZ-509252-A (NZ)
Title: Non-peptide GnRH agents for treating GnRH associated diseases with pyrazole carboxamidine related structures
Inventor: FAUST JAMES
IPC: A61K31/4375
Filed: 1999-08-20
Abstract: Non-peptide GnRH agents capable of inhibiting the effect of gonadotropin-releasing hormone are described. Such compounds and their pharmaceutically acceptable salts, multimers, prodrugs, and active metabolites are suitable for treating mammalian reproductive disorders and steroid hormone-dependent tumors as well as for regulating fertility, where suppression of gonadotropin release is indicated. Methods for synthesising the compounds and intermediates useful in their preparation are also described.
Patent NZ-513811-A (NZ)
Title: Pipe connector and method for production thereof
Inventor: EHRKE DIETER
IPC: F16L19/028
Filed: 2000-11-29
Abstract: A pipe connector for a pressure-resistant, positive-fit, high pressure screwed joint. The connection includes a formed tube (3); a screw body or connector branch with a cone (15), which connects to a parallel axis drilling, with a radial end surface; a union nut (2); a sealing ring (4); and a retaining ring (6). The formed tube has a parallel axis end-piece with the same tube diameter and which corresponds to the depth of the tube seat base. The formed tube has a torus (7) which forms a mating face (9) with a cone surface (8) of the union nut, and which leads to an abutment face (11) at a front face (12) of the retaining ring, essentially aligned with the tube axis. The retaining ring has a radial ring surface, which, in the assembled state, contacts with the front face of the cone of the connector branch or screw body, and thus permits a block assembly.
Patent NZ-514035-A (NZ)
Title: Earthquake-proofing reinforcing plate with bent twisted ends with rubber absorbing members between ends and structural members
Inventor: IWAKAWA TORU
IPC: E04B1/26
Filed: 2000-01-25
Abstract: The reinforcing holder is formed from a plate and has ends 1 formed by bending (with a twist) facing in one common direction. The end parts are fastened to structural members via elastic rubber absorbing members 2.
Patent NZ-514635-A (NZ)
Title: Camptothecin analogs and methods of preparation thereof
Inventor: CURRAN DENNIS P
IPC: C07F7/08
Filed: 2000-04-07
Abstract: A compound of formula (I) in racemic form, enantiomerically enriched form or enantiomerically pure form is disclosed wherein: R6 is preferably -Si(R8R9R10) or -(R7)Si(R8R9R10); R7 is an alkylene group, an alkenylene group, or an alkynylene group; and R8, R9 and R10 are independently a C1-10 alkyl group, a C2- 10 alkenyl group, a C2-10 alkynyl group, an aryl group or a -(CH2)NR11 group; wherein N is an integer within the range of 1 through 10; and R11 is a hydroxy group, alkoxy group, an amino group, an alkylamino group, a dialkylamino group, a halogen atom, a cyano group, -SRc or a nitro group. R1-R4 can be broadly substituted. R5 is preferably a C1-10 alkyl group, an alkenyl group, an alkynyl group, or a benzyl group. R13 is preferably H, F or -CH3. R16 is - C(O)Rf or H. The E-ring (the lactone ring) may be opened. A method of synthesis of compound (I) and intermediates in the synthesis thereof are disclosed.
Patent NZ-523717-A (NZ)
Title: Hemispherical dome for refractory vessel
Inventor: ABDULLAH ZIA
IPC: F27D1/04
Filed: 2003-01-21
Abstract: A refractory vessel (10) comprising a metal shell (12) having a generally cylindrical portion and an upper hemispherical dome (14). A refractory liner (20) has a cylindrical portion (22) spaced away from the cylindrical portion of the metal shell and a hemispherical portion (24) spaced inwardly from the dome. The hemispherical portion has a plurality of layers of refractory brick (40) forming successively higher and lesser diameter rings. At least a portion of the rings have mating keys and keyways to restrain the layers of bricks in a vertical direction.
Patent NZ-525498-A (NZ)
Title: Novel polymorphic forms of 5-[4-[2-[N-methyl-N-(2-pyridyl)amino]ethoxy]benzyl] thiazolidine-2,4-dione maleate and process for their preparation
Inventor: CHEBIYYAM PRABHAKAR
IPC: A61P9/10
Filed: 2001-09-25
Abstract: Polymorphic and pseudopolymorphic forms of 5-[4-[2[N-methyl-N-(2-pyridyl)amino]ethoxy]benzyl] thiazolidine-2,4-dione maleate having formula (I) and stereoisomers thereof, having a differential scanning calorimeter endotherm at 100.53°C and an onset at 88.65°C are disclosed. Pharmaceutical compositions comprising this polymorphic form or their mixture and a pharmaceutically acceptable carrier are also disclosed. These polymorphic forms are more active, as antidiabetic agent, than the previously known 5-[4-[2-[N-(2-methyl-N-(2-pyridyl)amino]ethoxy]benzyl] thiazolidine-2,4-dione maleate.
Patent NZ-525821-A (NZ)
Title: Excitatory amino acid receptor antagonists used in neurological disorders and neurodegenerative diseases
Inventor: KHAU VIEN VAN
IPC: A61K31/4725
Filed: 2001-12-20
Abstract: Excitatory amino acid receptor antagonists of formula (I) and formula (Ia), their pharmaceutically acceptable salts as well as methods for using the pharmaceutically acceptable salts, and also processes for making compounds of formula (I) and formula (Ia) are disclosed. These compounds of formula (I) and formula (Ia) are useful for the treatment of neurological disorders and neurodegenerative diseases, especially migraine.
Patent NZ-527625-A (NZ)
Title: Prevention of migraine recurrence using a 5-HT1B/1D receptor agonist such as eletriptan and pharmaceutical composition thereof
Inventor: JACKSON NEVILLE COLIN
IPC: A61K31/403
Filed: 2003-08-15
Abstract: A pharmaceutical composition comprising eletriptan, or a pharmaceutically acceptable salt thereof, use of eletriptan for the manufacture of a medicament for the prevention of migraine recurrence and the use of a 5-HT1B/1D receptor agonist, or a pharmaceutically acceptable salt or composition thereof, for the manufacture of a dual-, sustained-, delayed-, controlled- or pulsed-release pharmaceutical composition for the prevention of migraine recurrence is disclosed. (62) Divided out of 508736
Patent NZ-530107-A (NZ)
Title: Use of NK-1 receptor antagonists with pyridinic structure, for the treatment of brain, spinal or nerve injury
Inventor: HOFFMANN TORSTEN
IPC: A61P37/08
Filed: 2002-07-03
Abstract: Disclosed is the use of an NK-1 receptor antagonist for the manufacture of a medicament for the treatment and/or prevention of brain, spinal or nerve injury, wherein the NK-1 receptor antagonist is a compound of formula (I).
Patent NZ-532537-A (NZ)
Title: Prepaid account lottery system and method
Inventor: WEIL ALLAN LORNE
IPC: G06Q30/04
Filed: 2002-11-07
Abstract: A system and method of administering a lottery for a jurisdiction is disclosed. The lottery is conducted by a centralised lottery administrator (20) with lottery tickets being distributed by lottery agents (40) remote from the centralised lottery administrator (20). The method includes the steps of: (a) receiving from a wagerer (60) a communication identifying a unique identification code associated with a lottery card which has a monetary amount, where the lottery card is issued by a lottery agent (40); (b) after step (a) establishing, at a lottery administration system of the centralised lottery administrator (20), a user account associated with the unique identification code of the lottery card having the monetary amount; (c) receiving from the wagerer (60), without the assistance of a lottery agent (40) or lottery agent terminal, a communication identifying a first chosen play for a lottery game, where the first chosen play is associated with the user account; (d) deducting the cost of the chosen play from the balance of the user account. Where there is a remaining balance in the user account after the deduction, this is available for making at least one subsequent play; and (e) if it is verified that the chosen play is a winner, the winning monetary amount for the chosen play is credited to the user account, wherein the winning monetary amount may be redeemed from the user account upon presentation of the lottery card to an authorised lottery agent (60).
Patent NZ-533729-A (NZ)
Title: Method and apparatus for treatment of mono-frequency tinnitus
Inventor: CHOY DANIEL S J
IPC: H04R25/00
Filed: 2002-12-13
Abstract: Apparatus for treating mono-frequency tinnitus patients is disclosed. The apparatus includes a sound generator with selectable frequency and amplitude output controls so that a patient can subjectively set their tinnitus tone. A phase shift network incrementally shifts the selected tone through incremental segments totalling a 180 degree phase shift to achieve sound cancellation of the patient?s tinnitus. A portable audio storage device with a pre-recorded sound sequence for cancelling a patient?s tinnitus is also disclosed.
Patent NZ-535104-A (NZ)
Title: Automatic door and method of operating same
Inventor: GOODMAN CARL E
IPC: E05F15/20
Filed: 2003-02-19
Abstract: An automatic door and method of operating the same is provided. The door includes a first processor which may be located proximate a leading movable edge of the door and a second processor which is remotely located from the first processor. The first and second processors are operatively coupled with a bus configured to transmit digital signals there between. One or more input devices may be coupled with the first processor to indicate the status of an operational parameter of the door. Operational parameters are transmitted to the second processor, which controls a drive operatively coupled with the door to control the position thereof in response to such operational parameters. The second processor is configured such that, upon breakdown of communication between the first and second processors, the second processor causes the door to enter into a predetermined status.
Patent NZ-535517-A (NZ)
Title: Anxiolytic agents with reduced sedative and ataxic effects
Inventor: COOK JAMES M
IPC: A61P25/18
Filed: 2003-03-28
Abstract: Orally active benzodiazepine derivatives represented by the structures defined in the specification and their salts are disclosed. These compounds and their salts have anxiolytic and anticonvulsant activity with reduced sedative/hypnotic/muscle relaxant/ataxic effects.
Patent NZ-536129-A (NZ)
Title: Ventilating building sheet batten
Inventor: WEBSTER GRAEME BRUCE
Filed: 2004-10-26
Abstract: A ventilating and/or draining batten to be utilised as a spacer between timber framing and outer cladding in wall sections of the building elements, the batten being of a material selected from a plastic material, a non-moisture absorbing material or a non-moisture transmitting material and of an elongate strip like form of thickness of a desired set out distance, the batten having across its width transverse means whereby water can move through the strip like form.
Patent NZ-537729-A (NZ)
Title: Multi-functional product markers and methods for making and using the same
Inventor: NIGHTINGALE STEPHEN D
IPC: A23L1/00
Filed: 2003-06-23
Abstract: Disclosed are multi-functional markers for use on various products, particularly products which have one or more visually indistinguishable characteristics, for identifying and/or providing information about such products, and to processes and materials for making and using such markers.
Patent NZ-540693-A (NZ)
Title: Oil suspension concentrate for herbicidal compositions
Inventor: DECKWER ROLAND
IPC: A01N47/36
Filed: 2003-11-28
Abstract: An oil suspension concentrate suitable for preparing a herbicidal composition is disclosed wherein the oil suspension concentrate comprises: (a) one or more herbicidally active compounds selected from the group of sulfonamides and provided in suspended form; (b) one or more safeners; (c) one or more organic solvents, and; (d) one or more sulfosuccinates. The oil suspension concentrate is suited for use in the field of plant protection by controlling harmful plants.
Patent NZ-546107-A (NZ)
Title: Signal transmitting cable
Inventor: BROWN GEORGE HENRY PLATT
IPC: G02B6/44
Filed: 2003-06-26
Abstract: A cable assembly that includes a plurality of flexible signal transmitting members 2 is disclosed. The cable is arranged so that the signal transmitting members 2 are surrounded by a first layer 3 that restricts movement between at least the outermost members of the bundle. A continuous thermoplastic polymer second layer 4 surrounds the first layer and is adapted to be removed by sliding over the first layer.
Patent NZ-546276-A (NZ)
Title: A system of underwater power generation
Inventor: PERRY MICHAEL DAVID
IPC: F03B17/06
Filed: 2004-09-20
Abstract: An underwater power generation system (10) consisting of a number of foils(40) which are driven around a track by a current of water. The track lies in a plane that is perpendicular to the flow of water current. A power take-off is driven by the motion of foils and used to produce power.
Patent NZ-547042-A (NZ)
Title: Method for eliciting a T-cell response
Inventor: BRAUN RALPH PATRICK
IPC: C12Q/
Filed: 2004-10-12
Abstract: Provided is the use of a nucleotide sequence of interest (NOI) encoding a T cell epitope; and a protein comprising the T cell epitope; in the manufacture of a medicament to be administered to a mammal to elicit a T cell response against a T cell epitope in a host mammalian subject for treating or preventing a disease or condition that would benefit from a T-cell response, wherein the medicament is formulated for administration according to a dosage regime providing: (i) a first immunisation that comprises at least two administrations to the subject, wherein all subsequent administrations are given at least 2 and no more than 6 days after the first administration, and wherein each administration comprises administering a nucleotide sequence of interest (NOI) encoding a T cell epitope, and (ii) a second immunisation that comprises at least one administration to the subject of a protein comprising the T cell epitope, wherein the time between the first administration of the first immunisation, and the first administration of the second immunisation, is from 21 to 365 days.
Patent NZ-553667-A (NZ)
Title: A hinged stadium seat using straps with indica that also has a damped seat return movement to reduce noise
Inventor: KING SHELDON
IPC: A47C7/58
Filed: 2005-09-16
Abstract: A mounting system for connecting stadium seats (61) to a horizontally extending spine (47) is disclosed. The system simplifies the mounding process and provides for seat numbering at the same time. An elongate body (45) has a backrest (42) and a seat (49) mounted from it, the seat (49) able to pivot with respect to the body (45) and backrest (42). The underside of the body (45) which faces away from the backrest (42) is shaped to engage and mate with an upper region of the spine (47) but not extend beyond a lower region of the spine (47). At least one substantially inextensible flexible strip (72) extends entirely around both the spine (47) and mated body (45) and has its opposite ends joined together to strap the body (45) to the spine (47). The strip (72) may have an area (74) for displaying indicia such as seat numbers. The seat (61) may also be equipped with a damped seat return mechanism.
Patent NZ-563736-A (NZ)
Title: Inhibitors of cytosolic phospholipase A2
Inventor: MCKEW JOHN C
IPC: A61K31/404
Filed: 2006-05-26
Abstract: 3-{4-[(2-{5-chloro-1-(diphenylmethyl)-2-[2-({[2-(trifluoromethyl)benzyl]sulfonyl}amino)ethyl]-1H-indol-3-yl}ethyl)sulfonyl]phenyl}propanoic acid, and a pharmaceutically acceptable salt thereof is disclosed. Also disclosed is the use of said compound, or a pharmaceutically acceptable salt thereof, in the manufacture of a medicament for treating inflammation or pain caused or potentiated by prostaglandins, leukotrienes, or platelet activation factor in a mammal. This compound is particularly suitable for treating asthma, rheumatoid arthritis, osteoarthritis, juvenile arthritis, stroke, atherosclerosis, multiple sclerosis, Parkinson's disease, central nervous system damage resulting from stroke, central nervous system damage resulting from ischemia, and central nervous system damage resulting from trauma.